approximately 0 cameroonians had our 1978 ban

Here's the last one. It isn't a poisoning story. It's a business story.

February 2012. Someone on the lead safety peoples group email list forwarded a Pittsburgh Post-Gazette piece by Don Hopey. The subject line: PPG refuses to recall leaded paint in Cameroon.

PPG is an American paint company, one of the big ones. Most Americans have rolled one of their products onto a wall. In the United States, lead-based paint for residential use was banned in 1978, and the entire industry had, in theory, moved on. But the article was reporting that PPG was, in 2012, still selling a house paint with high lead content in Cameroon. Cameroon had no residential lead-paint ban. There was nothing technically illegal about it. Legal to manufacture in the US. Legal to export. Legal to sell at the point of destination.

The product itself was indefensible for US sale. That is why it wasn't sold here. So it was sold there.

This is where the whole series ends. Not with a child, not with an investigator, not with a regulator. With a ledger.

I said in the intro post that the villain isn't lead. The villain is decades of gatekeeping, industrial, regulatory, patent, attentional, that kept the hazard in circulation longer than it needed to be, and kept the tools to see it out of the hands of regular people. The PPG Cameroon story is the crispest example of the first half of that sentence I know. A product whose risk profile was so well-understood in its home market that the company would not have dreamed of selling it there, was shipped overseas and sold to families whose regulatory framework hadn't yet caught up to their right to not be poisoned.

There is a polite framing for this that gets used in business press, that regulatory arbitrage is the natural consequence of uneven regulation, that blame belongs to the destination country for failing to keep pace, that the company is just responding to market demand. I don't find any of that persuasive. If a product is unsafe here it is unsafe there. The regulatory patchwork is not an ethical cover.

The post to the list wasn't asking the members to do anything. It was a flag, here, this is happening, pay attention. Some of the list's members worked the international angle too, through a nonprofit coalition called IPEN that tracked lead-paint export for years. The post cross-posted because several US advocates worked both sides. It was the rare case where the American lead safety community was the back-channel to the global story, rather than the other way around.

There is no CIA for lead. There is also no CIA for lead across national borders. There is WHO, with real limits on enforcement. There is IPEN, a nonprofit coalition. There are dozens of country-level agencies operating at different levels of sophistication. There is no international primary-prevention body that can walk into a Cameroonian hardware store and say this can isn't allowed here anymore, because it isn't allowed anywhere else this same company sells. That job, if it exists, is split across industrial advocacy, legal pressure, voluntary company commitments, and the patience of the people buying the paint.

Every person in this story was doing an endpoint job. The Post-Gazette reporter wrote it. The American advocate posted it. The IPEN working group filed it. A few companies, quietly, over the following years, made voluntary commitments to phase out lead in export paint. Primary prevention, a rule that simply said you cannot ship outside the US what you are not allowed to sell inside the US, was, and remains, not in any agency's job description.

I said at the start of this series that lead is a test of whether a civilization can act on harm it cannot feel in its own body, in its own moment. Lead paint in Cameroon is that test in its purest form. We knew. We had written the ban. We knew the company. We knew the product. We knew the exposure pathway. The thing we did not have was a mechanism, legal or cultural, for saying we are not going to keep shipping this somewhere else.

Which is where these stories end.

The villain was never lead. The villain was decades of gatekeeping, industrial, regulatory, patent, attentional, that kept a workable tool out of regular people's hands, and kept a visible hazard on the shelves of people whose regulatory framework hadn't yet caught up.

The tool I've been making for the last several years is, at its root, an attempt to route around all of it. A chemistry that shows you lead with your own eyes, at a price regular people can pay, in fifteen seconds on a kitchen counter. It doesn't wait for EPA. It doesn't wait for FDA. It doesn't wait for an agency that has never existed to be built. It just tells you what's in front of you.

That's what the rest of this book is going to be about.

You can catch it with a flashlight and spray bottle in your hands.